2016
DOI: 10.1016/j.radonc.2015.12.028
|View full text |Cite
|
Sign up to set email alerts
|

Multi-criteria optimization achieves superior normal tissue sparing in a planning study of intensity-modulated radiation therapy for RTOG 1308-eligible non-small cell lung cancer patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
19
0

Year Published

2017
2017
2021
2021

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 31 publications
(20 citation statements)
references
References 23 publications
1
19
0
Order By: Relevance
“…Clinical physician times to coordinate and communicate with planners are on average 2 min for prostate and 5 min for brain cases. Plan review and approval take approximately 5 min for prostate and 10 min for brain cases (complexity comparable to lung tumors, average times published by [ 23 ]). Taking the number of iterations into account, physician times were estimated by 7 min for prostate (N = 1; t ph (CP) = t 3,ph (CP) ≅ 2 + 5 min) and 20–25 min for brain cases (N = 1.5; t ph (CP) = t 3,ph (CP) ≅ 1.5 × 15 min).…”
Section: Resultsmentioning
confidence: 99%
“…Clinical physician times to coordinate and communicate with planners are on average 2 min for prostate and 5 min for brain cases. Plan review and approval take approximately 5 min for prostate and 10 min for brain cases (complexity comparable to lung tumors, average times published by [ 23 ]). Taking the number of iterations into account, physician times were estimated by 7 min for prostate (N = 1; t ph (CP) = t 3,ph (CP) ≅ 2 + 5 min) and 20–25 min for brain cases (N = 1.5; t ph (CP) = t 3,ph (CP) ≅ 1.5 × 15 min).…”
Section: Resultsmentioning
confidence: 99%
“…The robustness of conventional IMPT plans, like ours, is lower since each beam is allowed to treat the complete CTV, which might especially be problematic for the posterior beam and the anterior target portions in the lower neck. Further advanced planning approaches34, 35, 36 and, in particular, robustness analyses36, 37, 38, 39, 40 need to be considered for future studies and to be translated into clinical practice. So far, there is no uniform consensus about the ideal IMPT planning strategy for HNC patients and robust optimization cannot be considered as clinical standard yet.…”
Section: Discussionmentioning
confidence: 99%
“…either binary decisions on whether plans were clinically acceptable 95,162,169,172 or giving plans a ranking. 93,103,164 Most studies are retrospective, comparing already delivered clinical plans with automatic plans.…”
Section: Clinical Evaluation and Implementation Of Automated Planningmentioning
confidence: 99%